SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5dbx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A52_B_ESTB2_1 (ESTROGEN RECEPTOR)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 10	MET A 268 ALA A 275 LEU A 278 ILE A 220 LEU A 189	None	1.40A	1a52B-5dbxA: undetectable	1a52B-5dbxA: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	ILE A 81 VAL A 89 ALA A 102 LEU A 152 GLY A 156 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None None	0.71A	2y7jA-5dbxA: 23.4	2y7jA-5dbxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 10	ILE A 81 ALA A 102 LEU A 152 GLY A 156 ASP A 160 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 ( 4.0A) None None None None	0.84A	2y7jC-5dbxA: 23.5	2y7jC-5dbxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 10	ILE A 81 VAL A 89 ALA A 102 LEU A 152 ASP A 160 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None None	0.75A	2y7jC-5dbxA: 23.5	2y7jC-5dbxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 10	ILE A 81 VAL A 89 ALA A 102 LEU A 152 ASP A 160 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None None	0.87A	2y7jD-5dbxA: 23.5	2y7jD-5dbxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	GLY A 82 ALA A 102 LYS A 104 VAL A 134 GLY A 156 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 ( 4.0A) ANP A 401 (-3.0A) None None None	0.55A	3c7qA-5dbxA: 20.4	3c7qA-5dbxA: 26.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CD2_A_MTXA307_1 (DIHYDROFOLATE REDUCTASE)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 12	ILE A 210 GLU A 277 ILE A 162 LEU A 362 ILE A 184	None	1.09A	3cd2A-5dbxA: undetectable	3cd2A-5dbxA: 21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CJT_G_SAMG302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 12	GLY A 208 LEU A 205 ASP A 160 LEU A 278 LEU A 176	None	1.10A	3cjtG-5dbxA: undetectable	3cjtG-5dbxA: 21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	8 / 12	GLY A 82 GLY A 84 VAL A 89 ALA A 102 VAL A 134 MET A 150 LEU A 153 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 (-3.3A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None ANP A 401 (-4.0A) ANP A 401 (-4.1A) None	0.73A	3fupB-5dbxA: 20.0	3fupB-5dbxA: 26.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 12	ALA A 352 LYS A 347 LEU A 328 LEU A 325 LEU A 344	None CAS A 346 ( 2.8A) None CAS A 346 ( 4.8A) None	1.03A	3hecA-5dbxA: 19.2	3hecA-5dbxA: 26.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	4 / 8	VAL A 133 VAL A 134 LEU A 211 ILE A 220	None	0.66A	3wzeA-5dbxA: 20.1	3wzeA-5dbxA: 28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	7 / 12	GLY A 82 VAL A 89 ALA A 102 LYS A 104 LEU A 148 GLY A 156 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-3.0A) None None None	0.46A	4ifgA-5dbxA: 23.2	4ifgA-5dbxA: 26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI504_0 (RNA POLYMERASE 3D-POL)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	3 / 3	VAL A 166 GLY A 169 LYS A 172	None	0.76A	4k50I-5dbxA: undetectable	4k50I-5dbxA: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KLR_A_CHDA504_0 (FERROCHELATASE, MITOCHONDRIAL)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	4 / 7	ARG A 72 ARG A 105 SER A 154 VAL A 80	None	1.26A	4klrA-5dbxA: undetectable	4klrA-5dbxA: 21.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	GLY A 82 VAL A 89 ALA A 102 MET A 150 LEU A 153 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-4.0A) ANP A 401 (-4.1A) None	0.58A	4qmzA-5dbxA: 27.8	4qmzA-5dbxA: 43.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	ILE A 81 GLY A 82 VAL A 89 ALA A 102 LEU A 153 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-4.1A) None	0.76A	4qmzA-5dbxA: 27.8	4qmzA-5dbxA: 43.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	VAL A 89 ALA A 102 LEU A 195 HIS A 202 ALA A 221 GLY A 224	ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None MG A 402 ( 4.6A) None	0.89A	4v04A-5dbxA: 20.7	4v04A-5dbxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZDZ_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	4 / 7	PHE A 349 THR A 274 LEU A 205 MET A 268	None	0.81A	4zdzA-5dbxA: undetectable	4zdzA-5dbxA: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A06_D_SORD1341_0 (ALDOSE-ALDOSE OXIDOREDUCTASE)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	4 / 6	GLU A 214 GLY A 213 GLY A 216 ASP A 215	None	0.95A	5a06D-5dbxA: undetectable	5a06D-5dbxA: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	ILE A 81 GLY A 82 VAL A 89 ALA A 102 VAL A 134 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None	0.67A	5l2iA-5dbxA: 5.2	5l2iA-5dbxA: 27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	ILE A 81 GLY A 82 VAL A 89 ALA A 102 VAL A 134 LEU A 211	ANP A 401 ( 4.1A) ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) None None	0.96A	5l2tA-5dbxA: 21.4	5l2tA-5dbxA: 27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 9	ILE A 81 GLY A 82 VAL A 89 ALA A 102 MET A 150	ANP A 401 ( 4.1A) ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-4.0A)	0.56A	5lw1B-5dbxA: 18.8	5lw1B-5dbxA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 10	GLY A 82 VAL A 89 ALA A 102 MET A 150 LEU A 152	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-4.0A) None	0.42A	5lw1E-5dbxA: 18.4	5lw1E-5dbxA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 9	GLY A 82 VAL A 89 ALA A 102 MET A 150 LEU A 152	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-4.0A) None	0.42A	5lw1H-5dbxA: 18.8	5lw1H-5dbxA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUR_E_PFLE406_1 (PROTON-GATED ION CHANNEL)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 10	ILE A 181 ILE A 180 ILE A 161 ILE A 162 ILE A 165	None	0.85A	5murE-5dbxA: undetectable	5murE-5dbxA: 12.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	6 / 12	GLY A 82 VAL A 89 ALA A 102 LYS A 104 LEU A 148 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-3.0A) None None	0.63A	5yu9A-5dbxA: 22.0	5yu9A-5dbxA: 14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	7 / 12	GLY A 82 VAL A 89 ALA A 102 LYS A 104 LEU A 148 ASP A 160 LEU A 211	ANP A 401 ( 3.9A) ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-3.0A) None None None	0.95A	5yu9B-5dbxA: 22.2	5yu9B-5dbxA: 14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 12	VAL A 89 ALA A 102 LYS A 104 LEU A 148 ASP A 160	ANP A 401 (-4.0A) ANP A 401 ( 4.0A) ANP A 401 (-3.0A) None None	0.70A	5yu9C-5dbxA: 22.0	5yu9C-5dbxA: 14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_G_TA1G501_1 (TUBULIN BETA CHAIN)	5dbx	STE20/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE (Mus musculus)	5 / 12	LEU A 330 ALA A 279 PHE A 322 LEU A 326 LEU A 185	None	1.10A	6ew0G-5dbxA: undetectable	6ew0G-5dbxA: 14.76

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A52_B_ESTB2_1","ESTROGEN RECEPTOR","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"MET A 268;ALA A 275;LEU A 278;ILE A 220;LEU A 189","None","1.40A","1a52B-5dbxA:undetectable","1a52B-5dbxA:20.82"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;VAL A  89;ALA A 102;LEU A 152;GLY A 156;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None;None","0.71A","2y7jA-5dbxA:23.4","2y7jA-5dbxA:28.02"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;ALA A 102;LEU A 152;GLY A 156;ASP A 160;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 ( 4.0A);None;None;None;None","0.84A","2y7jC-5dbxA:23.5","2y7jC-5dbxA:28.02"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;VAL A  89;ALA A 102;LEU A 152;ASP A 160;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None;None","0.75A","2y7jC-5dbxA:23.5","2y7jC-5dbxA:28.02"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;VAL A  89;ALA A 102;LEU A 152;ASP A 160;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None;None","0.87A","2y7jD-5dbxA:23.5","2y7jD-5dbxA:28.02"],["3C7Q_A_XINA1172_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"GLY A  82;ALA A 102;LYS A 104;VAL A 134;GLY A 156;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 ( 4.0A);ANP A 401 (-3.0A);None;None;None","0.55A","3c7qA-5dbxA:20.4","3c7qA-5dbxA:26.49"],["3CD2_A_MTXA307_1","DIHYDROFOLATE REDUCTASE","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"ILE A 210;GLU A 277;ILE A 162;LEU A 362;ILE A 184","None","1.09A","3cd2A-5dbxA:undetectable","3cd2A-5dbxA:21.86"],["3CJT_G_SAMG302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"GLY A 208;LEU A 205;ASP A 160;LEU A 278;LEU A 176","None","1.10A","3cjtG-5dbxA:undetectable","3cjtG-5dbxA:21.99"],["3FUP_B_MI1B1_1","TYROSINE-PROTEIN KINASE JAK2","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",8,"GLY A  82;GLY A  84;VAL A  89;ALA A 102;VAL A 134;MET A 150;LEU A 153;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 (-3.3A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;ANP A 401 (-4.0A);ANP A 401 (-4.1A);None","0.73A","3fupB-5dbxA:20.0","3fupB-5dbxA:26.06"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"ALA A 352;LYS A 347;LEU A 328;LEU A 325;LEU A 344","None;CAS A 346 ( 2.8A);None;CAS A 346 ( 4.8A);None","1.03A","3hecA-5dbxA:19.2","3hecA-5dbxA:26.81"],["3WZE_A_BAXA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",4,"VAL A 133;VAL A 134;LEU A 211;ILE A 220","None","0.66A","3wzeA-5dbxA:20.1","3wzeA-5dbxA:28.12"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",7,"GLY A  82;VAL A  89;ALA A 102;LYS A 104;LEU A 148;GLY A 156;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-3.0A);None;None;None","0.46A","4ifgA-5dbxA:23.2","4ifgA-5dbxA:26.76"],["4K50_I_ACTI504_0","RNA POLYMERASE 3D-POL","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",3,"VAL A 166;GLY A 169;LYS A 172","None","0.76A","4k50I-5dbxA:undetectable","4k50I-5dbxA:22.10"],["4KLR_A_CHDA504_0","FERROCHELATASE, MITOCHONDRIAL","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",4,"ARG A  72;ARG A 105;SER A 154;VAL A  80","None","1.26A","4klrA-5dbxA:undetectable","4klrA-5dbxA:21.88"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"GLY A  82;VAL A  89;ALA A 102;MET A 150;LEU A 153;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-4.0A);ANP A 401 (-4.1A);None","0.58A","4qmzA-5dbxA:27.8","4qmzA-5dbxA:43.52"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;GLY A  82;VAL A  89;ALA A 102;LEU A 153;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-4.1A);None","0.76A","4qmzA-5dbxA:27.8","4qmzA-5dbxA:43.52"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"VAL A  89;ALA A 102;LEU A 195;HIS A 202;ALA A 221;GLY A 224","ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None; MG A 402 ( 4.6A);None","0.89A","4v04A-5dbxA:20.7","4v04A-5dbxA:28.02"],["4ZDZ_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",4,"PHE A 349;THR A 274;LEU A 205;MET A 268","None","0.81A","4zdzA-5dbxA:undetectable","4zdzA-5dbxA:19.05"],["5A06_D_SORD1341_0","ALDOSE-ALDOSE OXIDOREDUCTASE","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",4,"GLU A 214;GLY A 213;GLY A 216;ASP A 215","None","0.95A","5a06D-5dbxA:undetectable","5a06D-5dbxA:21.35"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;GLY A  82;VAL A  89;ALA A 102;VAL A 134;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None","0.67A","5l2iA-5dbxA:5.2","5l2iA-5dbxA:27.27"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"ILE A  81;GLY A  82;VAL A  89;ALA A 102;VAL A 134;LEU A 211","ANP A 401 ( 4.1A);ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);None;None","0.96A","5l2tA-5dbxA:21.4","5l2tA-5dbxA:27.27"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"ILE A  81;GLY A  82;VAL A  89;ALA A 102;MET A 150","ANP A 401 ( 4.1A);ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-4.0A)","0.56A","5lw1B-5dbxA:18.8","5lw1B-5dbxA:14.15"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"GLY A  82;VAL A  89;ALA A 102;MET A 150;LEU A 152","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-4.0A);None","0.42A","5lw1E-5dbxA:18.4","5lw1E-5dbxA:14.15"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"GLY A  82;VAL A  89;ALA A 102;MET A 150;LEU A 152","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-4.0A);None","0.42A","5lw1H-5dbxA:18.8","5lw1H-5dbxA:14.15"],["5MUR_E_PFLE406_1","PROTON-GATED ION CHANNEL","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"ILE A 181;ILE A 180;ILE A 161;ILE A 162;ILE A 165","None","0.85A","5murE-5dbxA:undetectable","5murE-5dbxA:12.58"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",6,"GLY A  82;VAL A  89;ALA A 102;LYS A 104;LEU A 148;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-3.0A);None;None","0.63A","5yu9A-5dbxA:22.0","5yu9A-5dbxA:14.55"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",7,"GLY A  82;VAL A  89;ALA A 102;LYS A 104;LEU A 148;ASP A 160;LEU A 211","ANP A 401 ( 3.9A);ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-3.0A);None;None;None","0.95A","5yu9B-5dbxA:22.2","5yu9B-5dbxA:14.55"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"VAL A  89;ALA A 102;LYS A 104;LEU A 148;ASP A 160","ANP A 401 (-4.0A);ANP A 401 ( 4.0A);ANP A 401 (-3.0A);None;None","0.70A","5yu9C-5dbxA:22.0","5yu9C-5dbxA:14.55"],["6EW0_G_TA1G501_1","TUBULIN BETA CHAIN","5dbx","STE20\/SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE","Mus musculus",5,"LEU A 330;ALA A 279;PHE A 322;LEU A 326;LEU A 185","None","1.10A","6ew0G-5dbxA:undetectable","6ew0G-5dbxA:14.76"]]